Get the Stockscreener App
2.65
0.38%
0.010
After Hours:
2.65
Okyo Pharma Limited stock is traded at $2.65, with a volume of 710.03K.
It is up +0.38% in the last 24 hours and down -3.64% over the past month.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
See More
Previous Close:
$2.64
Open:
$2.8
24h Volume:
710.03K
Relative Volume:
3.56
Market Cap:
$99.67M
Revenue:
-
Net Income/Loss:
$-13.27M
P/E Ratio:
-16.16
EPS:
-0.164
Net Cash Flow:
$-7.70M
1W Performance:
-18.96%
1M Performance:
-3.64%
6M Performance:
+142.01%
1Y Performance:
+170.38%
1-Day Range:
$2.50
$2.92
1-Week Range:
$2.50
$3.33
52-Week Range:
$0.85
$3.349
Okyo Pharma Limited Stock (OKYO) Company Profile
Compare OKYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.65 | 99.29M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Okyo Pharma Limited Stock (OKYO) Latest News
Price action breakdown for OKYO Pharma LimitedTrend Reversal & Accurate Entry/Exit Alerts - Newser
What MACD signals say about OKYO Pharma LimitedJuly 2025 Volume & Fast Gain Swing Trade Alerts - Newser
Sentiment analysis tools applied to OKYO Pharma LimitedMarket Volume Summary & Reliable Momentum Entry Alerts - Newser
How to escape a deep drawdown in OKYO Pharma Limited2025 Top Gainers & Verified Momentum Stock Alerts - Newser
Exit strategy if you’re trapped in OKYO Pharma LimitedGold Moves & AI Forecast for Swing Trade Picks - Newser
Combining machine learning predictions for OKYO Pharma Limited2025 Winners & Losers & Free Safe Capital Growth Stock Tips - Newser
Is OKYO Pharma Limited forming a breakout patternQuarterly Investment Review & Precise Trade Entry Recommendations - sundaytimes.kr
Quantitative breakdown of OKYO Pharma Limited recent moveJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - Newser
Volume spikes in OKYO Pharma Limited stock – what they meanJuly 2025 Momentum & Accurate Entry and Exit Point Alerts - Newser
How institutional ownership impacts OKYO Pharma Limited stockMarket Movement Recap & Consistent Profit Trading Strategies - Newser
OKYO Pharma Limited stock trend forecastQuarterly Trade Report & Comprehensive Market Scan Insights - Newser
OKYO Pharma (NASDAQ:OKYO) Raised to "Hold" at Wall Street Zen - MarketBeat
How to build a custom watchlist for OKYO Pharma LimitedJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
Tools to assess OKYO Pharma Limited’s risk profileJuly 2025 Pullbacks & Stock Timing and Entry Methods - Newser
Published on: 2025-08-12 21:43:04 - Newser
Will a bounce in OKYO Pharma Limited offer an exitFree Daily Volume Spike Trading Signals - Newser
Visual analytics tools that track OKYO Pharma Limited performanceMomentum Entry Alerts with Risk Control - Newser
Is it too late to sell OKYO Pharma LimitedWealth Accumulation Outlook for Safe Investors - Newser
Can OKYO Pharma Limited rally from current levelsBuy Opportunity Forecast for Fast Traders - Newser
Why OKYO Pharma Limited stock attracts strong analyst attentionHigh Confidence Strategy with Trend Alignment - Newser
What candlestick patterns are forming on OKYO Pharma LimitedTrading Volume Spike and Reversal Analysis - Newser
Price momentum metrics for OKYO Pharma Limited explainedShort Squeeze Opportunities with Indicators - Newser
How to integrate OKYO Pharma Limited into portfolio analysis toolsFree Sector Rotation Based Trading Opportunities - Newser
OKYO Pharma (NASDAQ:OKYO) Raised to “Hold” at Wall Street Zen - Defense World
How OKYO Pharma Limited stock performs during market volatilityTrade Plan With Low Risk High Return - Newser
How to use a screener to detect OKYO Pharma Limited breakoutsFree Daily Momentum Screener With Alerts - Newser
Backtesting results for OKYO Pharma Limited trading strategiesFree Fundamental Growth Stock Analysis - Newser
Top chart patterns to watch in OKYO Pharma LimitedEarly Entry Ideas with Momentum Potential - Newser
Okyo Pharma Limited Stock (OKYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):